Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer. - Wikidata - awgldk - TriplyDB

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

http://www.wikidata.org/entity/Q37122690

about

Monitoring the Activation of the DNA Damage Response Pathway in a 3D Spheroid Model Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps FBXL5-mediated degradation of single-stranded DNA-binding protein hSSB1 controls DNA damage response.DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.Small Molecule Inhibitors of 8-Oxoguanine DNA Glycosylase-1 (OGG1).Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies.DNA damage response and sphingolipid signaling in liver diseases.Emerging therapeutic aspects in oncology.Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers.Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents

P2860

Q28546906-20A78AB2-D2CC-42BD-A726-8D5248BA9862 Q30659572-CAA460FD-EB1A-44A1-B500-C77EB6BCEA2E Q34313139-DB7CFE92-1880-4E5D-89CA-0AD449A8EAF4 Q35221075-8412210B-8CE1-4AB9-B3DC-82F91F2737D4 Q35720072-6E615E08-73A6-44F0-8189-80D0AECC6497 Q36787517-BB3E6A68-B498-43E1-932C-47BD00F2A94F Q38619642-2573905C-47F8-406C-8B4A-8DCAD84F361F Q39377645-B11C12BC-F212-4FF4-9B5C-0C1CF32AF56F Q55036989-44961C5F-9DAB-4CB5-9963-CB5FB3F1EBFA Q58772882-0277BEBC-14E7-4D32-9149-604A5067B969

P2860

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

http://www.wikidata.org/entity/Q37122690

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

@en

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

@nl

type

label

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

@en

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

@nl

prefLabel

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

@en

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

@nl

P1433

Q37122690-DA9DF4AC-6EC6-41EF-BF73-ED7A0825B150

P1476

Q37122690-11F7B046-3154-42D3-AD4B-F39EA2B03799

P2093

Q37122690-FDB963F6-61E9-428D-92A5-ED7B6DD5A8CA

P2860

Q37122690-0102A300-E181-42D5-930C-59703491F502

Q37122690-03D5E539-5A82-423B-B5F8-423014BFCD21

Q37122690-04736A87-B713-4F4D-B79A-4A3F98B89C30

Q37122690-04BF96E0-5FA0-43DB-AC5A-309C48493CF1

Q37122690-05EB4CDE-9761-44F4-8B9F-46FA5C35D0BD

Q37122690-06DFE353-7E8D-4692-8A48-7F2F50BC4FCE

Q37122690-07F24DD7-0CC7-40F4-B6C2-CE2E08D47796

Q37122690-0A2EFC9E-CC63-4E47-941D-0365772BE409

Q37122690-0A795436-AA7F-455C-A05B-EBFD34C37A62

Q37122690-0DCB4CC1-BCC0-4B2B-95B7-69E3BD64889A

P304

Q37122690-5614E098-EA02-4575-BF66-DC4CCF099DF0

P31

Q37122690-0885964E-3785-4A58-A412-D7A5ECBDF402

P356

Q37122690-5386D74E-5EC9-4E41-B72D-EAD3E9A7EE01

P407

Q37122690-427252F3-4C8D-4C60-986D-EE2DA35D4343

P433

Q37122690-FADD4C39-186A-4A36-81F7-1B15F5E6B053

P478

Q37122690-16C04DA0-551F-4E40-BC07-30D7E12EE6EA

P577

Q37122690-A006A841-C23D-459E-8E5F-C2CC0573781C

P698

Q37122690-793C4829-0BEC-4469-A67A-E99BEC00FA7A

P921

Q37122690-4EAF28A3-6023-4F1F-8FAF-C834B760E5BA

P932

Q37122690-188DF950-0BDF-4F48-929B-DD8AB3D07980

P356

P1433

British Journal of Pharmacology

P1476

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

@en

P2093

N J Curtin

http://www.w3.org/2001/XMLSchema#string

P2860

Instability and decay of the primary structure of DNA

Epigenetic changes of DNA repair genes in cancer

Hallmarks of Cancer: The Next Generation

Purified human BRCA2 stimulates RAD51-mediated recombination

XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining

Human cDNA expressing a functional DNA glycosylase excising 3-methyladenine and 7-methylguanine

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

Multiple roles of ATM in monitoring and maintaining DNA integrity

A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

P304

1745-1765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.12244

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23682925

http://www.w3.org/2001/XMLSchema#string

P921

P932

3753833

http://www.w3.org/2001/XMLSchema#string